Both in Biotechnology
Editas Medicine vs Eikon Therapeutics
Over the past year EDIT returned +73.3% and EIKN returned −64.5%; their daily moves had a correlation of 0.35.
EDIT +73.3% EIKN −64.5%Growth of $1, one year, split-adjusted
| Metric | EDIT | EIKN |
|---|---|---|
| Price | $2.89 | $5.32 |
| Market cap | $443.1M | $288.2M |
| Today | −2.20% | −3.97% |
| 1 month | +12.3% | −33.8% |
| 6 months | −3.8% | −44.7% |
| Year to date | +40.7% | — |
| 1 year | −9.0% | — |
| Revenue growth (YoY) | +232.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −153.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.4× | — |
| Net cash | $155.9M | $531.2M |
| Dividend yield | — | — |
| Volatility (60d) | 80.0% | 99.6% |
| Short % of float | 25.7% | 20.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).